General anaesthesia for caesarean delivery is uncommon, high-stakes and often performed by whoever is available at the time, which makes clear drug guidance disproportionately valuable. This umbrella review pulled together seven meta-analyses, two systematic reviews, 26 randomised trials and 15 observational studies, grouped into induction opioids, hypnotics, drugs to obtund the pressor response, and neuromuscular blockers.
Moderate-quality evidence supported short-acting opioids at induction, giving maternal haemodynamic benefit without adverse neonatal consequence — which addresses the long-standing reluctance to give opioids before delivery. Low-quality evidence favoured propofol over thiopental: equivalent early neonatal resuscitation requirements, with lower risk of maternal accidental awareness. Labetalol, dexmedetomidine, lidocaine and remifentanil all attenuated the pressor response to laryngoscopy with minimal neonatal effect. On moderate-quality evidence, rocuronium at 1 mg/kg or above gave intubating conditions comparable to suxamethonium without affecting neonatal outcomes.
The rocuronium finding matters most where sugammadex is stocked, since it removes the main argument for suxamethonium in a population at elevated risk of difficult airway. The stated limitation is important: high-risk pregnancies and emergency cases were excluded from the underlying evidence, and those are precisely the circumstances in which caesarean general anaesthesia is usually performed.
- Short-acting opioids at induction: maternal benefit without neonatal harm
- Propofol preferred over thiopental — less accidental awareness, equivalent neonatal outcome
- Rocuronium at 1 mg/kg or more comparable to suxamethonium
- Evidence excludes high-risk and emergency cases — where GA is mostly used
The statistics, in plain English
Note how the certainty ratings vary between recommendations that will be applied with equal confidence in practice. The rocuronium and opioid conclusions rest on moderate-quality evidence; the propofol recommendation, which is probably the most widely followed already, rests on low-quality evidence. That does not make it wrong, but it means the accidental-awareness advantage is less firmly established than its routine acceptance implies.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.
Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for anaesthesiology, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free